Latest & greatest articles for tamsulosin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tamsulosin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tamsulosin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tamsulosin

1. Efficacy and safety of Tamsulosin compared with Tamsulosin plus Dutasteride for treatment of Benign Prostatic Hyperplasia (BPH): a systematic review and meta-analysis

Efficacy and safety of Tamsulosin compared with Tamsulosin plus Dutasteride for treatment of Benign Prostatic Hyperplasia (BPH): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

2. To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: a systematic review and network meta-analysis

To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

3. Is tamsulosin effective on passage of symptomatic ureteral stones? A systematic review and meta-analysis

Is tamsulosin effective on passage of symptomatic ureteral stones? A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

4. Tamsulosin for the treatment of stent-related symptoms: a systematic review and meta-analysis of randomized trials

Tamsulosin for the treatment of stent-related symptoms: a systematic review and meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

5. The impact of urinary stone size and location on the efficacy of tamsulosin after shock wave lithotripsy: a systematic review

The impact of urinary stone size and location on the efficacy of tamsulosin after shock wave lithotripsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

6. Tamsulosin

Tamsulosin Top results for tamsulosin - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for tamsulosin The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

7. Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial Urinary stone disease is a common presentation in the emergency department, and α-adrenergic receptor blockers, such as tamsulosin, are commonly used to facilitate stone passage.To determine if tamsulosin promotes the passage of urinary stones within 28 days among emergency department patients.We conducted a double-blind, placebo-controlled clinical trial from 2008 to 2009 (first phase) and then from (...) 2012 to 2016 (second phase). Participants were followed for 90 days. The first phase was conducted at a single US emergency department; the second phase was conducted at 6 US emergency departments. Adult patients were eligible to participate if they presented with a symptomatic urinary stone in the ureter less than 9 mm in diameter, as demonstrated on computed tomography.Participants were randomized to treatment with either tamsulosin, 0.4 mg, or matching placebo daily for 28 days.The primary

2018 EvidenceUpdates

8. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial (Abstract)

Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Recent large high-quality trials have questioned the clinical effectiveness of medical expulsive therapy using tamsulosin for ureteral stones.To evaluate the efficacy and safety of tamsulosin for distal ureteral stones compared with placebo.We conducted a double-blind, placebo-controlled study of 3296 patients with distal (...) ureteral stones, across 30 centers, to evaluate the efficacy and safety of tamsulosin.Participants were randomly assigned (1:1) into tamsulosin (0.4mg) or placebo groups for 4 wk.The primary end point of analysis was the overall stone expulsion rate, defined as stone expulsion, confirmed by negative findings on computed tomography, over a 28-d surveillance period. Secondary end points included time to stone expulsion, use of analgesics, and incidence of adverse events.Among 3450 patients randomized

2018 EvidenceUpdates

9. Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones: a systematic review and meta-analysis

Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

10. Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones - a meta-analysis

Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones - a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

11. Comparison of the efficacy and safety of tamsulosin or tolterodine in monotherapy vs combination therapy for ureteral stent related symptoms

Comparison of the efficacy and safety of tamsulosin or tolterodine in monotherapy vs combination therapy for ureteral stent related symptoms Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

12. Tamsulosin as a medical expulsive therapy for ureteral stones: a systematic review and meta-analysis of randomized controlled trials

Tamsulosin as a medical expulsive therapy for ureteral stones: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

13. The efficacy of tamsulosin in the expulsion of ureteral stones

The efficacy of tamsulosin in the expulsion of ureteral stones Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2018 PROSPERO

14. Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for benign prostatic hyperplasia

Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for benign prostatic hyperplasia '); } else { document.write(' '); } ACE | Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for benign prostatic hyperplasia Search > > Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for benign prostatic hyperplasia - Dutasteride, tamsulosin, alfuzosin and dutasteride/tamsulosin combination for the treatment of benign prostatic hyperplasia (...) Published on 2 July 2018 Guidance Recommendations The Ministry of Health's Drug Advisory Committee has recommended: Alfuzosin 10mg tablet for the treatment of benign prostatic hyperplasia. Subsidy status Alfuzosin 10mg tablet is recommended for inclusion on the MOH Standard Drug List (SDL). SDL subsidy does not apply to tamsulosin 0.4mg tablet, dutasteride 0.5mg capsule or dutasteride 0.5mg/tamsulosin 0.4mg capsule. Factors considered to inform the recommendations for subsidy Technology evaluation Point

2018 Appropriate Care Guides, Agency for Care Effectiveness (Singapore)

15. Tamsulosin for the Expulsion of Ureteral Stones

Tamsulosin for the Expulsion of Ureteral Stones Emergency Medicine > Journal Club > Archive > September 2016 Toggle navigation September 2016 Tamsulosin for the Expulsion of Ureteral Stones Vignette You are working in TCC one busy evening, kicking ass and saving lives. In the middle of the primary survey of a critically ill level one trauma, you are suddenly hit by a sharp, 10 out of 10 pain in your right side. Thinking that Doug Schueurer might have punched you, you turn around swiftly and see (...) wonder if there is any real efficacy. When you get home, you decide to do a literature search and see what the evidence shows. PICO Question Population: Adult patients with ureteral stones not requiring urgent surgical intervention Intervention: Tamsulosin Comparison: Usual treatment (oral hydration, pain control, etc.) Outcome: Time to stone passage, pain level, need for surgical intervention, quality of life, patient satisfaction Search Strategy The articles chosen for the 2008 journal club were

2017 Washington University Emergency Medicine Journal Club

16. COMBODART (dutasteride + tamsulosin), 5-? reductase inhibitor + alpha-blocker

COMBODART (dutasteride + tamsulosin), 5-? reductase inhibitor + alpha-blocker Haute Autorité de Santé - COMBODART (dutastéride + tamsulosine), inhibiteur de la 5-α réductase + alpha-bloquant Développer la qualité dans le champ sanitaire, social et médico-social Recherche Évaluation & Recommandation La HAS Accréditation & Certification Outils, Guides & Méthodes Agenda Avis sur les Médicaments COMBODART (dutastéride + tamsulosine), inhibiteur de la 5-α réductase + alpha-bloquant Substance active (...) (DCI) dutastéride tamsulosine (chlorhydrate de) UROLOGIE - Mise au point Nature de la demande Réévaluation SMR Avis de la CT du 14 décembre 2016 Intérêt clinique faible de COMBODART en remplacement de la prise séparée de tamsulosine et de dutastéride, si cette association en prise séparée est bien tolérée durant au moins 6 mois de traitement. COMBODART a l’AMM dans le traitement des symptômes modérés à sévères de l'hypertrophie bénigne de la prostate (HBP) et pour la réduction du risque de

2017 Haute Autorite de sante

17. Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis Full Text available with Trip Pro

Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis Tamsulosin is recommended for patients receiving a diagnosis of a ureteral stone less than 10 mm who do not require immediate urologic intervention. Because of conflicting results from recent meta-analyses and large randomized controlled trials, the efficacy of tamsulosin is unclear. We perform a systematic review and meta-analysis to investigate the effect of tamsulosin on stone passage in patients (...) receiving a diagnosis of ureteral stone.MEDLINE, EMBASE, and CENTRAL databases were searched without language restriction through November 2015 for studies assessing the efficacy of tamsulosin and using a double-blind, randomized, controlled trial design. Meta-analysis was conducted with a random-effects model and subgroup analyses were conducted to determine sources of heterogeneity.Eight randomized controlled trials (N=1,384) contained sufficient information for inclusion. The pooled risk of stone

2016 EvidenceUpdates

18. Randomised controlled trial: Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease

Randomised controlled trial: Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone

2016 Evidence-Based Medicine

19. Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial Full Text available with Trip Pro

Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial We assess the efficacy and safety of tamsulosin compared with placebo as medical expulsive therapy in patients with distal ureteric stones less than or equal to 10 mm in diameter.This was a randomized, double-blind, placebo-controlled, multicenter trial of adult participants with calculus on computed tomography (CT). Patients were allocated to 0.4 mg of tamsulosin or placebo daily for 28 (...) days. The primary outcomes were stone expulsion on CT at 28 days and time to stone expulsion.There were 403 patients randomized, 81.4% were men, and the median age was 46 years. The median stone size was 4.0 mm in the tamsulosin group and 3.7 mm in the placebo group. Of 316 patients who received CT at 28 days, stone passage occurred in 140 of 161 (87.0%) in the tamsulosin group and 127 of 155 (81.9%) with placebo, a difference of 5.0% (95% confidence interval -3.0% to 13.0%). In a prespecified

2015 EvidenceUpdates Controlled trial quality: predicted high

20. Effectiveness of tamsulosin on stone passage in distal ureteral stones: a systematic review and meta-analysis

Effectiveness of tamsulosin on stone passage in distal ureteral stones: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2015 PROSPERO